Grantham, Mayo, Van Otterloo & Co (GMO)’s Accendra Health ACH Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-36,200	Closed	-$872K	–	761
2022 Q3	$872K	Sell	36,200 -6,600	-15%	-$203K	0.01%	514
2022 Q2	$1.35M	Buy	+42,800	New	+$1.55M	0.01%	486
2021 Q3	–	Sell	-91,384	Closed	-$3.87M	–	744
2021 Q2	$3.87M	Sell	91,384 -128,935	-59%	-$5.02M	0.02%	378
2021 Q1	$8.28M	Sell	220,319 -278,181	-56%	-$8.7M	0.05%	252
2020 Q4	$13.5M	Sell	498,500 -128,500	-20%	-$3.31M	0.08%	170
2020 Q3	$15.7M	Buy	627,000 +134,700	+27%	+$1.96M	0.11%	111
2020 Q2	$3.75M	Buy	+492,300	New	+$3.6M	0.03%	289
2014 Q4	–	Sell	-9,211	Closed	-$302K	–	461
2014 Q3	$302K	Buy	+9,211	New	+$313K	﹤0.01%	416

Other funds holding ACH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ACH Position: Q4 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Accendra Health (ACH) in Q4 2022, closing a stake of 36,200 shares — an estimated $872K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ACH in Q3 2014 and held it in 8 quarters. The position peaked at $15.7M in Q3 2020. 219 funds tracked by Wall St. Rank hold ACH as of Q4 2022.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Accendra Health position as of Q4 2022 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 36,200 Accendra Health shares in Q4 2022, an estimated $872K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Accendra Health in Q3 2014 and held it in 8 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Accendra Health position peaked at $15.7M in Q3 2020.
219 funds tracked by Wall St. Rank held Accendra Health as of Q4 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2022, filed 13 Feb 2023.